Sunrest Lifescience Limited is an India-based pharmaceutical company. The Company is engaged in the business of selling healthcare products, medicines, and cosmetics. It deals in capsules, tablets, syrup, ointment, gel, mouth wash, solution, suspension, dry powders, and toothpaste. The Company’s product portfolio comprises a range of drugs like Anti-Bacterial, Anti-Diarrheal, Antifungal, Anti Malerial, Anti-Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti-Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory. The Company operates in different states of India, such as Maharashtra, Gujarat, Madhya Pradesh, Odisha, and Rajasthan. The Company works on a third-party manufacturing basis or at times a purchase order basis with manufacturers of pharma products, depending upon the customer’s requirements.As of 14 Jun 2026, SUNREST share price is ₹33.90. The stock opened at ₹33.00, compared to its previous close of ₹33.10. During today's trading session, SUNREST share price moved in the range of ₹33.00 to ₹33.90, with an average price of ₹33.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹33.00 and a high of ₹33.90. On the performance front, SUNREST share price has declined by 21.16% over the last six months and is down 30.82% on a year-on-year basis.
The market capitalization of SUNREST is ₹29 Crs and a dividend yield of 0.00%.